Content area
Full Text
For years, treatments for ADHD have included various kinds of stimulant medications (such as Ritalin). In 2002, a medication, called Strattera, was approved for ADHD. Now, the U.S. Food and Drug Administration (FDA) is alerting caregivers that children being treated with Strattera should be closely monitored to be sure their symptoms don't get worse, and that they don't develop agitation, irritability, changes in behavior, or suicidal thinking or behaviors, especially during the first few months of treatment or when doses are changed (either up or down). Parents who have concerns should contact their health care provider.
The warning came after a review of 13 clinical studies of children treated with...